Stroke/Vascular Neurology News

Three triage options for patients receiving endovascular treatment for stroke conferred similarly good clinical outcomes, researchers reported.

Intracerebral hemorrhage correlated with an increased risk for ischemic stroke and myocardial infarction, according to results from an analysis of four population-based, U.S. cohort studies that was published in JAMA Neurology.

Delays in care after acute ischemic stroke correlated with loss of healthy life-years among patients treated with endovascular thrombectomy, especially in the post-arrival period, according to findings published in JAMA Neurology.

Neighborhood socioeconomic status significantly influenced recovery outcomes following a stroke, particularly a moderate to severe stroke, according to a population-based surveillance study published in Neurology.

Women with a history of preeclampsia had a greater risk for stroke later in life, according to a secondary analysis of data from the Framingham Heart Study.

Americans belonging to racial, ethnic, or socioeconomic minority groups experienced a higher burden of stroke, according to results from the All of Us Research Program presented at the American Academy of Neurology Annual Meeting.

The FDA announced in a press release its marketing authorization and breakthrough device designation of the IpsiHand Upper Extremity Rehabilitation System from Neurolutions Inc. for use in stroke patients.

Stroke burden varied by racial/ethnic groups, with higher adjusted prevalence and incidence among Black participants compared with white participants, according to findings from a cross-sectional cohort study of more than 220,000 patients.

Race, ethnicity and health insurance status all appeared to impact receipt of treatment for ischemic stroke among patients in California, Florida and New York, according to a retrospective analysis of more than 1 million hospitalizations.

The U.S. Preventive Services Task Force announced there is insufficient evidence to make a recommendation on screening asymptomatic patients aged 50 years and older for atrial fibrillation.